GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » EV-to-FCF

Sinocelltech Group (SHSE:688520) EV-to-FCF : -62.54 (As of Jun. 29, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sinocelltech Group's Enterprise Value is ¥28,647 Mil. Sinocelltech Group's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-458 Mil. Therefore, Sinocelltech Group's EV-to-FCF for today is -62.54.

The historical rank and industry rank for Sinocelltech Group's EV-to-FCF or its related term are showing as below:

SHSE:688520' s EV-to-FCF Range Over the Past 10 Years
Min: -122.18   Med: -28.79   Max: -16.92
Current: -49.17

During the past 9 years, the highest EV-to-FCF of Sinocelltech Group was -16.92. The lowest was -122.18. And the median was -28.79.

SHSE:688520's EV-to-FCF is ranked worse than
100% of 408 companies
in the Biotechnology industry
Industry Median: 6.27 vs SHSE:688520: -49.17

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-06-29), Sinocelltech Group's stock price is ¥58.90. Sinocelltech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.200. Therefore, Sinocelltech Group's PE Ratio (TTM) for today is 294.50.


Sinocelltech Group EV-to-FCF Historical Data

The historical data trend for Sinocelltech Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group EV-to-FCF Chart

Sinocelltech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only -29.75 -24.77 -28.15 -29.75 -73.28

Sinocelltech Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.01 -51.60 -127.28 -73.28 -44.88

Competitive Comparison of Sinocelltech Group's EV-to-FCF

For the Biotechnology subindustry, Sinocelltech Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinocelltech Group's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinocelltech Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sinocelltech Group's EV-to-FCF falls into.


;
;

Sinocelltech Group EV-to-FCF Calculation

Sinocelltech Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=28647.364/-458.083
=-62.54

Sinocelltech Group's current Enterprise Value is ¥28,647 Mil.
Sinocelltech Group's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-458 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinocelltech Group  (SHSE:688520) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Sinocelltech Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=58.90/0.200
=294.50

Sinocelltech Group's share price for today is ¥58.90.
Sinocelltech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.200.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sinocelltech Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sinocelltech Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocelltech Group Business Description

Traded in Other Exchanges
N/A
Address
Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176
Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.
Executives
Xie Liang Zhi Director

Sinocelltech Group Headlines

No Headlines